January 2, 2018 - New York (N.Y.) -Cellectis(Euronext Growth: ALCLS - Nasdaq: CLLS), a clinical-stage biopharmaceutical company focused on developing immunotherapies based on gene-edited allogeneic CAR T-cells (UCART), announced today that Dr. André Choulika, Chairman and Chief Executive Officer of Cellectis, will present at the 36 Annual J.P. Morgan Healthcare Conference on Monday, January 8, 2018 at 12:00 p.m. Pacific Time in the Elizabethan A/B room. A Q&A session will follow at 1:30 p.m. PT in the Sussex room. The conference will be held from January 8 to 11, 2018 at the Westin St. Francis Hotel in San Francisco, CA.
To access the live webcast of Cellectis presentation and subsequent breakout session, please visithttp://www.cellectis.com/en/agenda/. A replay of the webcast will be available on Cellectis website for 90 days.
Cellectis SA published this content on 02 January 2018 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 02 January 2018 21:49:00 UTC.
Original documenthttp://www.cellectis.com/en/press/cellectis-to-present-at-the-36th-annual-j.p.-morgan-healthcare-conference-on-monday-january-8-2018-at-1200pm-pt/
Public permalinkhttp://www.publicnow.com/view/B53E3352C63F13E23AC6964CC76C5A31F9513DBB
